Dapagliflozin attenuates residual cardiac remodeling after surgical ventricular reconstruction in mice with an enlarged heart after myocardial infarction
Background: Severe heart failure refractory to conventional therapy requires alternative treatment modalities. Surgical ventricular reconstruction (SVR) has been used to reverse cardiac remodeling in post-myocardial infarction (MI) patients with large left ventricular (LV) aneurysm, however, residua...
Main Authors: | Siyuan Ma, Lu Chen, Junyu Yan, Mengjia Shen, Rui Zhang, Mingjue Li, Mingyuan He, Kaitong Chen, Yingqi Zhu, Hairuo Lin, Yuegang Wang, Wangjun Liao, Jianping Bin, Cankun Zheng, Yulin Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222011544 |
Similar Items
-
SGLT2 inhibitor therapy for transthyretin amyloid cardiomyopathy: early tolerance and clinical response to dapagliflozin
by: Stephan Dobner, et al.
Published: (2023-02-01) -
LCZ696 (sacubitril/valsartan) inhibits pulmonary hypertension induced right ventricular remodeling by targeting pyruvate dehydrogenase kinase 4
by: Mengjia Shen, et al.
Published: (2023-06-01) -
Dapagliflozin treatment and cardiovascular outcome in RBP4/TTRVal30Met (transthyretin cardiac amyloidosis) mice
by: Zonglin Li, et al.
Published: (2024-02-01) -
Dapagliflozin Regulates Cardiac Metabolic Remodeling Partially via Uncoupling Protein 3 in a Nondiabetic Thoracic Aortic Constriction-Induced Mouse Model
by: Li-Wen Bao, et al.
Published: (2021-01-01) -
Prevention of left ventricular remodeling after myocardial infarction: efficacy of physical training
by: Camillo Taglieri, et al.
Published: (2016-01-01)